In addition, increased CDH6 expression has been reported in several malignancies (including nasopharyngeal, ovarian, oral squamous cell, and renal cancers) and is associated with lymph node metastases and a poor prognosis [18–20]. This evidence concerns the gene CDH6 and renal carcinoma.